FDA Approves New Prostate Cancer Imaging Agent Gozellix®

Go back to FDA Approves New Prostate Cancer Imaging Agent Gozellix®
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.51 +0.06 (0.63%)
Previous Close $9.45    52 Week High $2.18 
Open $9.42    52 Week Low $0.30 
Day High $9.60    P/E N/A 
Day Low $9.42    EPS $-3.32 
Volume 184,124       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.51 +0.06 (0.63%)
Previous Close $9.45    52 Week High $2.18 
Open $9.42    52 Week Low $0.30 
Day High $9.60    P/E N/A 
Day Low $9.42    EPS $-3.32 
Volume 184,124